ViiV Healthcare Australia's Positive Action Community Grant (PACG) program supports innovative, grassroots projects that reach those most affected by ...
Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's interest and simplifies the shareholder structure of the HIV specialist. Under ...
Shionogi doubles stake in ViiV Healthcare to 21.7% Pfizer exits ViiV Healthcare for $1.9 billion Transaction completion expected in Q1 2026 GSK retains majority stake in ViiV Healthcare at 78.3% ...
As Pfizer sells its stake in ViiV Healthcare, Japan-based Shionogi & Co will increase its hold in the human immunodeficiency virus (HIV) medicines developer in a $2.13bn deal. ViiV Healthcare, which ...
Five weeks after telling investors to expect a revenue decline in 2026, Pfizer has found a quick funding fix, selling off its stake in GSK’s ViiV Healthcare. The New York powerhouse has agreed to ...
Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it would pay $2.13 billion for new shares in ViiV Healthcare, its joint venture with British drugmaker GSK, increasing its stake in the HIV ...
Shionogi and GSK will acquire Pfizer's 11.7% stake in ViiV Healthcare, increasing Shionogi's holdings to 21.7%. The transaction simplifies ViiV's shareholder structure, leaving GSK and Shionogi as the ...
GSK plc (GSK), and Shionogi & Co., Ltd (Shionogi) announced that they have reached agreement together with Pfizer Inc. for the 11.7% economic interest in ViiV Healthcare Limited (ViiV Healthcare) ...
Pfizer is getting out of the business of developing and marketing HIV medicines by exiting its minority stake in ViiV Healthcare, a company the pharmaceutical giant formed in partnership with GSK 17 ...
Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV specialist ViiV Healthcare in a deal that pays the U.S. drugmaker $1.9 billion and more than doubles Shionogi's ...
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) will exit their HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results